|
⚲
|
| Keyboard |
| Gangloff Scott A
✚
|
|
|---|---|
| CIK # | 0001663253 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001663253] | |
| 4 | [0001663253] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gangloff Scott A | |
| Akero Therapeutics Inc | |
| Outlook Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 204,616 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-12-09 | Disposed to issuer | 21,263 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-12-09 | Disposed to issuer | 5,088 | ||
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 17,784 | ||
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 73,700 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-08-15 | Option exercise | 2,600 | $19.62 | 51,012 |
|
Akero Therapeutics Inc AKRO
Stock option (Right to Buy) · derivative
|
2025-08-15 | Option exercise | 2,600 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-06-30 | Grant | 299 | $23.87 | 7,137 |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2025-06-18 | Sell | 848 | $54.84 | 46,504 |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2024-12-16 | Grant | 24,300 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2024-12-16 | Grant | 73,700 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Stock Option (Right to Buy) · derivative
|
2024-04-29 | Grant | 225,000 | $0.00 | |
|
Outlook Therapeutics Inc ONS
Common Stock
|
2016-12-21 | Grant | 40,000 | $0.00 | |
|
Outlook Therapeutics Inc ONS
Common Stock
|
2016-11-11 | Sell | 37,369 | $3.75 | 140,134 |
|
Outlook Therapeutics Inc ONS
Common Stock
|
2016-11-09 | Option exercise | 115,942 | ||
|
Outlook Therapeutics Inc ONS
Restricted Stock Units
|
2016-11-09 | Conversion | 115,942 | $0.00 |